Results 41 to 50 of about 2,709 (155)

Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma

open access: yesJournal for ImmunoTherapy of Cancer, 2021
Background Osteosarcoma is the most common malignant solid tumor that affects bones, however, survival rates of patients with relapsed osteosarcoma have not improved in the last 30 years.
Alvaro Morales-Molina   +3 more
doaj   +1 more source

The Roles of Different Multigene Combinations of , , , , and in the Reprogramming of Canine ADSCs Into IPCs

open access: yesCell Transplantation, 2022
Adipose-derived mesenchymal stem cells (ADSCs) are ideal sources for the treatment of diabetes, and the differentiation of ADSCs into insulin-producing cells (IPCs) through transfection of exogenous regulatory genes in vitro has been studied in depth ...
Dengke Gao   +4 more
doaj   +1 more source

Relationship between Adenoviruses and Canine Hepatitis Virus [PDF]

open access: yesNature, 1964
IT was shown by Kapsenberg1 and Heller and Salenstedt2 that infectious canine hepatitis virus (ICH) and adenoviruses possessed common complement fixing antigens. Heller and Salenstedt2 demonstrated five precipitin lines in Ouchterlony plates in the reaction between ICH and convalescent serum from a dog infected with ICH.
openaire   +2 more sources

Novel adenoviruses detected in British mustelids, including a unique Aviadenovirus in the tissues of pine martens (Martes martes). [PDF]

open access: yes, 2017
Several adenoviruses are known to cause severe disease in veterinary species. Recent evidence suggests that canine adenovirus type 1 (CAV-1) persists in the tissues of healthy red foxes (Vulpes vulpes), which may be a source of infection for susceptible ...
Meredith, Anna L.   +6 more
core   +2 more sources

Tropism-modification strategies for targeted gene delivery using adenoviral vectors [PDF]

open access: yes, 2010
Achieving high efficiency, targeted gene delivery with adenoviral vectors is a long-standing goal in the field of clinical gene therapy. To achieve this, platform vectors must combine efficient retargeting strategies with detargeting modifications to ...
Coughlan, L.   +20 more
core   +1 more source

Evaluation of a Point-of-Care Test for Pre-Vaccination Testing to Detect Antibodies against Canine Adenoviruses in Dogs

open access: yes, 2023
(1) Background: Antibody testing is commonly used to assess a dog’s immune status. For detection of antibodies against canine adenoviruses (CAVs), one point-of-care (POC) test is available. This study assessed the POC test´s performance.
Bergmann, Michèle   +5 more
core   +2 more sources

An Update on Canine Adenovirus Type 2 and Its Vectors

open access: yesViruses, 2010
Adenovirus vectors have significant potential for long- or short-term gene transfer. Preclinical and clinical studies using human derived adenoviruses (HAd) have demonstrated the feasibility of flexible hybrid vector designs, robust expression and ...
Eric J. Kremer   +2 more
doaj   +1 more source

The cell adhesion molecule "CAR" and sialic acid on human erythrocytes influence adenovirus in vivo biodistribution.

open access: yesPLoS Pathogens, 2009
Although it has been known for 50 years that adenoviruses (Ads) interact with erythrocytes ex vivo, the molecular and structural basis for this interaction, which has been serendipitously exploited for diagnostic tests, is unknown.
Elena Seiradake   +15 more
doaj   +1 more source

Ca2+‐Activated Cl− Channels: Do Bestrophins and TMEM16A Interact?

open access: yesActa Physiologica, Volume 242, Issue 6, June 2026.
ABSTRACT Aim Ca2+‐activated Cl– conductances are present in many cell types and are important for regulating membrane potential as well as other cellular functions. TMEM16A is widely accepted as the principal molecular basis for Ca2+‐activated Cl– conductances, but also members of the bestrophin family may be important for some Ca2+‐activated Cl ...
Christian Aalkjær   +4 more
wiley   +1 more source

Emerging Roles of Adenosine Metabolism in Astrocytes During Brain Injury

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 5, May 2026.
Adenosine, as a key metabolic and neurotransmitter in the brain, has become an important therapeutic target for improving the efficacy of immunotherapy for stroke. However, gaps in knowledge about its metabolic pathways have become a key factor limiting its clinical translation.
Shu Zhu   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy